← FDA Drug Approvals (Drugs@FDA)

SUGAMMADEX SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2026-07-28

Drug application

FDA Application #

ANDA219448

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUGAMMADEX SODIUM

Generic name

SUGAMMADEX

Active ingredients

SUGAMMADEX SODIUM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2026-07-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown